$ZSAN Zosano Pharma Corp Insider Trading
Get free email notifications about insider trading in Zosano Pharma Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zosano Pharma Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Zosano Pharma Corp for free.
CIK Number: 0001587221
IRS Number: 454488360
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ZSAN
Company Address: 34790 ARDENTECH COURT FREMONT 94555
Phone number: 510-745-1200
Former name: ZP Holdings Inc, date of change: 2013-09-19
Market Capitalization: $19.67M
Prev close: $1.20
Average Daily Volume: 224,111
Days Low: $1.14
Year Low: $0.45
Year High: $2.83
Zosano Pharma Corp Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
Jun 14 2021 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Grant | A | 0.00 | 15,000 | 0 | 22,500 | 7.5 K to 22.5 K (+200.00 %) |
Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
Jun 14 2021 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Grant | A | 0.00 | 15,000 | 0 | 23,596 | 8.6 K to 23.6 K (+174.50 %) |
Jun 07 2021 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Sell | S | 0.81 | 1,709 | 1,376 | 50,337 | 52 K to 50.3 K (-3.28 %) |
Jun 07 2021 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Sell | S | 0.81 | 1,709 | 1,376 | 50,337 | 52 K to 50.3 K (-3.28 %) |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.20 | 465,000 | 558,000 | 465,000 | |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Grant | A | 0.00 | 232,500 | 0 | 378,750 | 146.3 K to 378.8 K (+158.97 %) |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lewis Hayley | See Remarks | Option Exercise | A | 1.20 | 65,000 | 78,000 | 65,000 | |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lewis Hayley | See Remarks | Grant | A | 0.00 | 32,500 | 0 | 51,488 | 19 K to 51.5 K (+171.16 %) |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Option Exercise | A | 1.20 | 65,000 | 78,000 | 65,000 | |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Grant | A | 0.00 | 32,500 | 0 | 52,046 | 19.5 K to 52 K (+166.27 %) |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Matthews Christine | Chief Financial Off ... | Option Exercise | A | 1.20 | 162,500 | 195,000 | 162,500 | |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Matthews Christine | Chief Financial Off ... | Grant | A | 0.00 | 81,250 | 0 | 100,000 | 18.8 K to 100 K (+433.33 %) |
Apr 01 2021 | ZSAN | Zosano Pharma Corp | Lo Steven | Chief Executive Off ... | Option Exercise | A | 1.20 | 465,000 | 558,000 | 465,000 |